Effects of factors inducing diffuse damage to brain tissue on sleep structure in laboratory rats.
Chronic experiments on laboratory rats with implanted electrodes for recording neocortical and hippocampal EEG and cervical muscle electromyogram traces were performed to study the effects of strong treatments inducing diffuse damage to brain tissue on subsequent sleep. Four different experimental models were used: one "chronic" (generalized cerebral ischemia induced by permanent occlusion of one of the common carotid arteries) and three "acute" (hypoxic hypoxia, hypoglycemia, and "penicillin" epilepsy). Sleep recordings were made in freely moving animals either day-round (in the "chronic" model) or daily for 3 h ("acute" models). In all models, traces showed significant increases in the mean total duration of paradoxical sleep, reaching a peak 1-3 days after treatment. The subsequent dynamics depended on the treatment used: in the "acute" models, the duration of paradoxical sleep returned to control levels in 5-6 days, while in the "chronic" model, this occurred at 40-45 days after the beginning of treatment. The sharp increases in the durations of paradoxical sleep after use of strong treatments inducing damage to brain tissue can be regarded as supporting the suggestion that there is an increase in neuronal recovery processes during paradoxical sleep.
Kovalzon
V M
VM
A. N. Severtsov Institute of Ecology and Evolution, Russian Academy of Sciences, Moscow, Russia. kovalzon@sevin.ru
Dorokhov
V B
VB
Loginov
V V
VV
D000818:Animals; D002545:Brain Ischemia / Q000503:physiopathology; D004569:Electroencephalography; D004827:Epilepsy / Q000139:chemically induced; D006624:Hippocampus / Q000503:physiopathology*; D007003:Hypoglycemia / Q000139:chemically induced; D008297:Male; D019579:Neocortex / Q000503:physiopathology*; D010406:Penicillins / Q000494:pharmacology; D051381:Rats; D012890:Sleep / Q000502:physiology*; D012895:Sleep, REM / Q000502:physiology*
D010406:Penicillins
Neurosci Biobehav Rev. 2008;32(1):99-117
17764741
Trends Neurosci. 2000 Jun;23(6):265-71
10838596
Acta Neuropathol. 1980;50(1):31-41
6990679
Nature. 1969 Aug 30;223(5209):893-7
4308512
Toxicol Lett. 2003 Apr 4;139(2-3):221-7
12628758
Neuroscience. 2006 Oct 13;142(2):315-31
16887278
Brain Res. 2000 Jan 24;853(2):323-9
10640630
Behav Brain Res. 2005 May 7;160(1):107-14
15836905
J Sleep Res. 2003 Mar;12(1):25-34
12603784
Brain Res. 2002 Jul 26;945(1):1-8
12113945
Physiol Rev. 1999 Oct;79(4):1431-568
10508238
Sleep. 2006 Oct;29(10):1339-44
17068988
Trends Neurosci. 1999 Sep;22(9):391-7
10441299
Zh Evol Biokhim Fiziol. 1993 Sep-Dec;29(5-6):627-34
7825391
Brain Res. 2003 Sep 12;984(1-2):170-81
12932851
Prostaglandins Other Lipid Mediat. 2005 Sep;77(1-4):65-76
16099392
Neurosci Lett. 2004 Apr 29;360(3):133-6
15082151
Neuroscience. 2005;130(4):1029-40
15652998
Brain Res Mol Brain Res. 2001 Aug 15;92(1-2):157-66
11483252
Zh Vyssh Nerv Deiat Im I P Pavlova. 2003 Nov-Dec;53(6):677-80
14959481
Epilepsia. 2005 Nov;46(11):1724-43
16302852
Brain Res Bull. 2006 Apr 28;69(4):375-81
16624668
Eur J Neurosci. 2005 Oct;22(8):2111-6
16262649
Sleep Med Rev. 2001 Feb;5(1):63-77
12531045
Sleep. 2002 Feb 1;25(1):18-24
11833856
Electroencephalogr Clin Neurophysiol. 1975 Dec;39(6):663-6
53146
Sleep Med Rev. 2002 Aug;6(4):321-32
12531135